Literature DB >> 10998225

Multiple isolates from aids patients: aspects of an analysis by a genotypic marker and antimicrobial susceptibilities variations.

M H Saad1, M A Telles, F Porfirio, L Ferrazoli, L de Souza Fonseca, W Johnson, L W Riley.   

Abstract

Twenty-one Mycobacterium avium multisolates, from ten human immunodeficiency virus-infected patients, were typed by restriction fragment length polymorphism using as marker the IS1245 and characterized by minimum inhibitory concentration for nine different antibiotics. Two out of four patients harboring multisolates with different fingerprint profile, were therefore considered as having a polyclonal infection, since their isolates were taken from sterile site. This result confirms that polyclonal infection caused by M. avium occurs with a nonnegligenciable frequency. Analyzing the multisolates susceptibility profile of each patient it was observed that most of them were infected with strains having appreciably different antimicrobial susceptibility patterns, no matter what the genotypic pattern of the strains was. These results have strong implication for the treatment of the patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998225     DOI: 10.1590/s0074-02762000000500021

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  2 in total

1.  Low-intensity ultrasound promotes the horizontal transfer of resistance genes mediated by plasmids in E. coli.

Authors:  Lei Song; Xin Wang; Weiyan Zhang; Lei Ye; Xing Feng
Journal:  3 Biotech       Date:  2018-04-20       Impact factor: 2.406

2.  IS1311 and IS1245 restriction fragment length polymorphism analyses, serotypes, and drug susceptibilities of Mycobacterium avium complex isolates obtained from a human immunodeficiency virus-negative patient.

Authors:  Lenka Dvorska; Milan Bartos; Oldrich Ostadal; Jarmila Kaustova; Ludmila Matlova; Ivo Pavlik
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.